Recent Updates
Recently added Catalysts
LLY Positive Sentiment

Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC Eli Lilly and Company (NYSE: LLY) will host a webcast on Monday, July 17, 2023 at the Alzheimer's Association International Conference. The webcast...

Tuesday, July 11, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Eli Lilly and Company will host a webcast on July 17, 2023, during the Alzheimer's Association International Conference. The event will focus primarily on the results of the donanemab TRAILBLAZER-ALZ 2 clinical trial, providing important updates in the Alzheimer's disease landscape. Attendees will be able to access the live audio webcast and later view a replay on Lilly's Investor website.
Price reaction · baseline $453.16 (2023-07-10 close) · hit after-hours · 1 other LLY headline(s) in the window, move may be shared
day 0 close · peak
-3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lilly is providing an update on significant Alzheimer's disease research.
  • The webcast will cover results from the critical donanemab TRAILBLAZER-ALZ 2 trial.
  • Engagement with stakeholders through this public webcast indicates transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , July 11, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will host a webcast on Monday, July 17, 2023 at the Alzheimer's Association International Conference. The webcast will begin at 1:30 p.m. Eastern time , and remarks will primarily focus on results from the donanemab TRAILBLAZER-ALZ 2 clinical trial, as well as the broader landscape in Alzheimer's disease.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
Refer to: Jordan Bishop; [email protected] ; 317-473-5712 (Media)
Joe Fletcher; [email protected] ; 317-296-2884 (Investors)

Frequently Asked Questions

When is Eli Lilly's webcast at the Alzheimer's Conference?

The webcast is scheduled for July 17, 2023, at 1:30 p.m. Eastern time.

What will Eli Lilly discuss during the webcast?

The focus will be on results from the donanemab TRAILBLAZER-ALZ 2 trial.

Where can I watch the Eli Lilly webcast?

It will be available on Lilly's Investor website under 'Webcasts & Presentations.'

How long will the webcast replay be available?

The replay will be accessible for approximately 90 days post-presentation.

Who can I contact for more information about the webcast?

Contact Jordan Bishop for media inquiries and Joe Fletcher for investor questions.

ShareAdd on Google
Tags: LLY Viatris Investor Conferences Healthcare Eli Lilly Alzheimer’s disease donanemab TRAILBLAZER-ALZ 2 AAIC
Last updated: Jul 11, 2023

Biotech snapshot

Cash runway
$8950M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DulaglutidePhase 3
Type 2 Diabetes Mellitus →

Catalyst track record

+45%
best trade around LLY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for LLY.

See every catalyst's timing & PoA →